济川药业：子公司陕西东科获得利多卡因凝胶贴膏药品注册证书

Core Viewpoint - Jichuan Pharmaceutical's subsidiary, Shaanxi Dongke, has received approval from the National Medical Products Administration for the registration certificate of Lidocaine Gel Patch, which is intended for alleviating postherpetic neuralgia [2] Company Summary - The approval of the Lidocaine Gel Patch is seen as a significant addition to the company's product line, which is expected to positively impact its future development [2] - Currently, there are four companies in China, including Shaanxi Dongke, that have been approved for the Lidocaine Gel Patch [2] Industry Summary - The market development cycle for the newly approved drug may be lengthy and is subject to uncertainties influenced by industry policies and procurement bidding [2]